NVST
Price
$20.79
Change
-$0.19 (-0.91%)
Updated
Sep 18, 01:22 PM (EDT)
Capitalization
3.51B
41 days until earnings call
STAA
Price
$27.28
Change
+$0.12 (+0.44%)
Updated
Sep 18, 01:49 PM (EDT)
Capitalization
1.35B
41 days until earnings call
Interact to see
Advertisement

NVST vs STAA

Header iconNVST vs STAA Comparison
Open Charts NVST vs STAABanner chart's image
Envista Holdings
Price$20.79
Change-$0.19 (-0.91%)
Volume$1K
Capitalization3.51B
STAAR Surgical
Price$27.28
Change+$0.12 (+0.44%)
Volume$300
Capitalization1.35B
NVST vs STAA Comparison Chart in %
Loading...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STAA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVST vs. STAA commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVST is a Hold and STAA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (NVST: $20.98 vs. STAA: $27.17)
Brand notoriety: NVST and STAA are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NVST: 91% vs. STAA: 53%
Market capitalization -- NVST: $3.51B vs. STAA: $1.35B
NVST [@Pharmaceuticals: Other] is valued at $3.51B. STAA’s [@Pharmaceuticals: Other] market capitalization is $1.35B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $155.76B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVST’s FA Score shows that 0 FA rating(s) are green whileSTAA’s FA Score has 0 green FA rating(s).

  • NVST’s FA Score: 0 green, 5 red.
  • STAA’s FA Score: 0 green, 5 red.
According to our system of comparison, NVST is a better buy in the long-term than STAA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVST’s TA Score shows that 4 TA indicator(s) are bullish while STAA’s TA Score has 3 bullish TA indicator(s).

  • NVST’s TA Score: 4 bullish, 4 bearish.
  • STAA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, NVST is a better buy in the short-term than STAA.

Price Growth

NVST (@Pharmaceuticals: Other) experienced а +1.01% price change this week, while STAA (@Pharmaceuticals: Other) price change was -1.79% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.31%. For the same industry, the average monthly price growth was +2.43%, and the average quarterly price growth was +6.56%.

Reported Earning Dates

NVST is expected to report earnings on Oct 29, 2025.

STAA is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.31% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVST($3.51B) has a higher market cap than STAA($1.35B). NVST has higher P/E ratio than STAA: NVST (65.56) vs STAA (49.73). STAA YTD gains are higher at: 11.836 vs. NVST (8.761). NVST has higher annual earnings (EBITDA): 303M vs. STAA (-73.24M). NVST has more cash in the bank: 1.11B vs. STAA (190M). STAA has less debt than NVST: STAA (40.5M) vs NVST (1.6B). NVST has higher revenues than STAA: NVST (2.55B) vs STAA (224M).
NVSTSTAANVST / STAA
Capitalization3.51B1.35B260%
EBITDA303M-73.24M-414%
Gain YTD8.76111.83674%
P/E Ratio65.5649.73132%
Revenue2.55B224M1,140%
Total Cash1.11B190M585%
Total Debt1.6B40.5M3,941%
FUNDAMENTALS RATINGS
NVST vs STAA: Fundamental Ratings
NVST
STAA
OUTLOOK RATING
1..100
7353
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
86
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9196
PRICE GROWTH RATING
1..100
4842
P/E GROWTH RATING
1..100
4687
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVST's Valuation (73) in the null industry is in the same range as STAA (86) in the Medical Specialties industry. This means that NVST’s stock grew similarly to STAA’s over the last 12 months.

NVST's Profit vs Risk Rating (100) in the null industry is in the same range as STAA (100) in the Medical Specialties industry. This means that NVST’s stock grew similarly to STAA’s over the last 12 months.

NVST's SMR Rating (91) in the null industry is in the same range as STAA (96) in the Medical Specialties industry. This means that NVST’s stock grew similarly to STAA’s over the last 12 months.

STAA's Price Growth Rating (42) in the Medical Specialties industry is in the same range as NVST (48) in the null industry. This means that STAA’s stock grew similarly to NVST’s over the last 12 months.

NVST's P/E Growth Rating (46) in the null industry is somewhat better than the same rating for STAA (87) in the Medical Specialties industry. This means that NVST’s stock grew somewhat faster than STAA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVSTSTAA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 14 days ago
66%
Bullish Trend 14 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STAA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CTAGX17.060.03
+0.18%
Calamos Timpani SMID Growth A
HDPMX84.54N/A
N/A
Hodges Retail
BCSIX45.59N/A
N/A
Brown Capital Mgmt Small Co Inv
EIVCX14.43N/A
N/A
Allspring Special Large Cap Value C
JVAPX38.67N/A
N/A
JPMorgan Value Advantage R3

NVST and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVST has been loosely correlated with BIO. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NVST jumps, then BIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVST
1D Price
Change %
NVST100%
-0.57%
BIO - NVST
57%
Loosely correlated
-0.70%
A - NVST
55%
Loosely correlated
-0.37%
XRAY - NVST
54%
Loosely correlated
-1.40%
ALGN - NVST
54%
Loosely correlated
-1.81%
AZTA - NVST
53%
Loosely correlated
-0.42%
More

STAA and

Correlation & Price change

A.I.dvisor indicates that over the last year, STAA has been loosely correlated with XRAY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if STAA jumps, then XRAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STAA
1D Price
Change %
STAA100%
-0.24%
XRAY - STAA
53%
Loosely correlated
-1.40%
WST - STAA
44%
Loosely correlated
-0.66%
OFIX - STAA
38%
Loosely correlated
+0.67%
CSTL - STAA
38%
Loosely correlated
+0.32%
IQV - STAA
37%
Loosely correlated
-0.06%
More